GPT Healthcare (NSE:GPTHEALTH) Marketable Securities: ₹429 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GPTHEALTH GPT Healthcare Ltd NSE:GPTHEALTH
43 GF Score
Price ₹159.44
! 3 Warning Signs
View Full Analysis

What is GPT Healthcare Marketable Securities?

GPT Healthcare NSE:GPTHEALTH -3.39% 43 Marketable Securities is ₹429 Mil as of Mar. 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 43/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. GPT Healthcare's Marketable Securities for the quarter that ended in Mar. 2026 was ₹429 Mil.

GPT Healthcare's annual Marketable Securities increased from Mar. 2024 (₹173 Mil) to Mar. 2025 (₹320 Mil) and increased from Mar. 2025 (₹320 Mil) to Mar. 2026 (₹429 Mil).

GPT Healthcare  (NSE:GPTHEALTH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

GPT Healthcare Marketable Securities Related Terms

GPT Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for GPT Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GPT Healthcare Marketable Securities Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 53.93 102.76 173.38 319.80 429.36

GPT Healthcare Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 319.80 0.00 354.09 0.00 429.36
NSE:GPTHEALTH
43GF Score
GPT Healthcare Ltd NSE:GPTHEALTH
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GPT Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹429 Mil mean?
GPT Healthcare (NSE:GPTHEALTH) has a Marketable Securities of ₹429 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GPT Healthcare and its competitors.
Is GPT Healthcare's Marketable Securities too high?
GPT Healthcare's current Marketable Securities is ₹429 Mil. Overall, GPT Healthcare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Marketable Securities compare to HCA and THC?
GPT Healthcare's Marketable Securities of ₹429 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GPT Healthcare and its competitors. GPT Healthcare's current Marketable Securities is ₹429 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Marketable Securities of ₹429 Mil. The current Marketable Securities is ₹429 Mil. GPT Healthcare's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Marketable Securities is ₹429 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GPT Healthcare Business Description

Other Exchanges 544131:India
Address Sector III, GPT Centre, JC-25, Salt Lake, Kolkata, WB, IND, 700106
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
43GF Score

Get the complete analysis for NSE:GPTHEALTH

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹159.44
Price